Arthritis Research & Therapy

official impact factor 4.36

Letter

Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome

Hennie G Raterman1, Alexandre E Voskuyl1, Ben AC Dijkmans1,2 and Michael T Nurmohamed3*

Author Affiliations

1 Department of Rheumatology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands

2 Department of Rheumatology, Jan van Breemen Institue, Dr Janvan Breemenstraat 2, 1056 AB Amsterdam, The Netherlands

3 Department of Internal Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands

For all author emails, please log on.

Arthritis Research & Therapy 2009, 11:413 doi:10.1186/ar2805

Published: 21 September 2009

Abstract